Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Peder Rustøen, Braadland"'
Autor:
Ingrid Jenny Guldvik, Peder Rustøen Braadland, Shivanthe Sivanesan, Håkon Ramberg, Gitte Kristensen, Pierre Tennstedt, Andreas Røder, Thorsten Schlomm, Viktor Berge, Lars Magne Eri, Wolfgang Lilleby, Ian G. Mills, Kristin Austlid Taskén
Publikováno v:
European Urology Open Science, Vol 45, Iss , Pp 68-75 (2022)
Background: After radical prostatectomy (RP), depending on stage, up to 40% of patients with prostate cancer (PCa) will experience biochemical failure (BF). Despite salvage therapy, approximately one-third of these patients will need permanent hormon
Externí odkaz:
https://doaj.org/article/4bb9e8665eca453fb6a2b5e1d3055677
Autor:
Peder Rustøen Braadland, Kai Markus Schneider, Annika Bergquist, Antonio Molinaro, Anita Lövgren-Sandblom, Marcus Henricsson, Tom Hemming Karlsen, Mette Vesterhus, Christian Trautwein, Johannes Roksund Hov, Hanns-Ulrich Marschall
Publikováno v:
JHEP Reports, Vol 4, Iss 11, Pp 100561- (2022)
Background & Aims: Farnesoid X receptor (FXR) agonists and fibroblast growth factor 19 (FGF19) analogues suppress bile acid synthesis and are being investigated for their potential therapeutic efficacy in cholestatic liver diseases. We investigated w
Externí odkaz:
https://doaj.org/article/5da6d93d1b724ac6b4d7ca6c74b5971b
Autor:
Peder Rustøen Braadland, Anastassia Serguienko, Ola Myklebost, Leonardo A. Meza-Zepeda, Bodil Bjerkehagen
Publikováno v:
Clinical Sarcoma Research, Vol 10, Iss 1, Pp 1-11 (2020)
Clinical Sarcoma Research
Clinical Sarcoma Research
Background Well- and dedifferentiated liposarcoma (WD/DDLPS) are rare mesenchymal malignant tumors that account for 20% of all sarcomas in adults. The WD form is a low-grade malignancy with a favourable prognosis which may progress to DDLPS, a high-g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55754ea36faff7b51edca2289685a360
http://link.springer.com/article/10.1186/s13569-020-0126-1
http://link.springer.com/article/10.1186/s13569-020-0126-1
Publikováno v:
Frontiers in Oncology, Vol 4 (2015)
Enhanced sympathetic signaling, often associated with obesity and chronic stress, is increasingly acknowledged as a contributor to cancer aggressiveness. In prostate cancer, intact sympathetic nerves are critical for tumor formation, and sympathectom
Externí odkaz:
https://doaj.org/article/88ae5114d24042128c73bea7552d9215
Autor:
Sigve Andersen, Gustavo A. de Souza, Kristin Austlid Taskén, Olov Ögren, Aud Svindland, Maria Stensland, Viktor Berge, Elin Richardsen, Peder Rustøen Braadland, Ståle Nygård, Ingrid Jenny Guldvik, Mehrdad Rakaee, Håkon Ramberg
Publikováno v:
Carcinogenesis
The demographic shift toward an older population will increase the number of prostate cancer cases. A challenge in the treatment of prostate cancer is to avoid undertreatment of patients at high risk of progression following curative treatment. These
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f59649c885cda1d70fd6664ccc09169a
https://hdl.handle.net/10037/22207
https://hdl.handle.net/10037/22207
Autor:
Rune Kvåle, Anne George, Håkon Ramberg, Vincent J. Gnanapragasam, Fredrik Wiklund, David E. Neal, Ian G. Mills, Wolfgang Lilleby, Ingrid Jenny Guldvik, Helene Hartvedt Grytli, Verena Zuber, Kristin Austlid Taskén, Fahri Saatcioglu, Manuela Zucknick, Bernd Thiede, Peder Rustøen Braadland, Randi Elin Gislefoss, Henrik Grönberg
Publikováno v:
European Urology Open Science
Guldvik, I J, Zuber, V, Braadland, P R, Grytli, H H, Ramberg, H, Lilleby, W, Thiede, B, Zucknick, M, Saatcioglu, F, Gislefoss, R, Kvåle, R, George, A, Grönberg, H, Wiklund, F, Neal, D E, Gnanapragasam, V J, Taskén, K A & Mills, I G 2020, ' Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification ', European Urology Open Science, vol. 21, pp. 51-60 . https://doi.org/10.1016/j.euros.2020.08.007
European Urology Open Science, Vol 21, Iss, Pp 51-60 (2020)
Guldvik, I J, Zuber, V, Braadland, P R, Grytli, H H, Ramberg, H, Lilleby, W, Thiede, B, Zucknick, M, Saatcioglu, F, Gislefoss, R, Kvåle, R, George, A, Grönberg, H, Wiklund, F, Neal, D E, Gnanapragasam, V J, Taskén, K A & Mills, I G 2020, ' Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification ', European Urology Open Science, vol. 21, pp. 51-60 . https://doi.org/10.1016/j.euros.2020.08.007
European Urology Open Science, Vol 21, Iss, Pp 51-60 (2020)
Background More accurate risk assessments are needed to improve prostate cancer management. Objective To identify blood-based protein biomarkers that provided prognostic information for risk stratification. Design, setting, and participants Mass spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d574d67b6dd00873fa6e18be16bbce24
https://ora.ox.ac.uk/objects/uuid:e8e889a7-3ba0-4a65-ba17-e02f617c8684
https://ora.ox.ac.uk/objects/uuid:e8e889a7-3ba0-4a65-ba17-e02f617c8684
Autor:
Anders Bjartell, Heidi Kristin Nielsen, Aud Svindland, Helene Hartvedt Grytli, Andreas Engedal, Alfonso Urbanucci, Wanzhong Wang, Kirsi Ketola, Håkon Ramberg, Peder Rustøen Braadland, Kristin Austlid Taskén, Ian G. Mills, Ingrid Jenny Guldvik
The incidence of treatment-related neuroendocrine prostate cancer (t-NEPC) is rising as more potent drugs targeting the androgen signaling axis are clinically implemented. Neuroendocrine transdifferentiation (NEtD), an putative initial step in t-NEPC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4882db7745a829ccff6779a7b2efe1
https://doi.org/10.1158/1541-7786.mcr-18-0605
https://doi.org/10.1158/1541-7786.mcr-18-0605
Publikováno v:
Endocrine-related cancer. 26(4)
Tumor evolution is based on the ability to constantly mutate and activate different pathways under the selective pressure of targeted therapies. Epigenetic alterations including those of the chromatin structure are associated with tumor initiation, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7cb8dff31766495aae6c6604bc081a6
https://pubmed.ncbi.nlm.nih.gov/30844748
https://pubmed.ncbi.nlm.nih.gov/30844748
Autor:
Betina Katz, Peder Rustøen Braadland, Helene Hartvedt Grytli, Kurt A. Krobert, Viktor Berge, Olivier Barbier, Gunhild Mari Mælandsmo, Aud Svindland, Gunnar Mellgren, Wanzhong Wang, Ralf Kellman, Louis Gauthier-Landry, Kristin Austlid Taskén, Anders Bjartell, Finn Olav Levy, Paul S. Rennie, Ladan Fazli, Håkon Ramberg
Publikováno v:
Oncotarget. 7:1878-1894
Publisher's version, source at http://doi.org/10.18632/oncotarget.6479. The underlying mechanisms responsible for the development of castration-resistant prostate cancer (CRPC) in patients who have undergone androgen deprivation therapy are not fully
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a25c73a4c9b36dda2f2b9a27d42e9824
https://doi.org/10.18632/oncotarget.6479
https://doi.org/10.18632/oncotarget.6479
Autor:
Helena Bertilsson, Tone Frost Bathen, Betina Katz, Peder Rustøen Braadland, Ingrid Jenny Guldvik, Kristin Austlid Taskén, Lars M. Eri, Ståle Nygård, Elise Sandsmark, Ailin Falkmo Hansen, May-Britt Tessem, Guro F. Giskeødegård, Helene Hartvedt Grytli, Kirsten Margrete Selnæs, Viktor Berge, Aud Svindland, Leslie R. Euceda
Publikováno v:
British Journal of Cancer
Background: Robust biomarkers that identify prostate cancer patients with high risk of recurrence will improve personalised cancer care. In this study, we investigated whether tissue metabolites detectable by high-resolution magic angle spinning magn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9392a6dc3d41fd0c5b5c2cf8630db20
https://hdl.handle.net/11250/2478175
https://hdl.handle.net/11250/2478175